A Phase II Randomized , Double-blind , Multicenter Study to Evaluate Ef fi cacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Con fi rmed to be Due to Gram-positive Pathogens